Abdominal and neurological symptoms as an early sign of lung cancer: A manifestation of the anti-Hu syndrome;Buikklachten en neurologische symptomen als vroege manifestatie van longkanker: Een uiting van het anti-Hu-syndroom

Nederlands Tijdschrift voor Geneeskunde

Volumn 147, Issue 13, 2003, Pages 616-619

  Wymenga, A N M ^a   Slebos, D J ^a   Van Der Naalt, J ^a   Van Putten, J W G ^a   Peters, F T M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; HU ANTIBODY; UNCLASSIFIED DRUG;

ABDOMINAL DISEASE; ADULT; AGED; ARTICLE; CASE REPORT; DISEASE COURSE; FEMALE; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL MOTILITY DISORDER; GASTROINTESTINAL SYMPTOM; HUMAN; LUNG CANCER; LUNG SMALL CELL CANCER; NEUROLOGIC DISEASE; OUTCOMES RESEARCH; PARANEOPLASTIC SYNDROME; PROGNOSIS;

AGED; AUTOANTIBODIES; CARCINOMA, SMALL CELL; DIAGNOSIS, DIFFERENTIAL; FEMALE; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MOTILITY; HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; NERVE TISSUE PROTEINS; NERVOUS SYSTEM DISEASES; PARANEOPLASTIC SYNDROMES; PROGNOSIS; RNA-BINDING PROTEINS;

EID: 0037471813     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Chinn JS, Schuffler MD. Paraneoplastic visceral neuropathy as a cause of severe gastrointestinal motor dysfunction. Gastroenterology 1988;95:1279-86.
2. Lennon VA, Sas DF, Busk MF, Scheithauer B, Malagelada JR, Camilleri M, et al. Enteric neuronal autoantibodies in pseudoobstruction with small-cell lung carcinoma. Gastroenterology 1991;100:137-42.
3. Graus F, Cordon-Cardo C, Posner JB. Neuron-specific antinuclear antibody in a patient with oat cell of the lung and subacute sensory neuronopathy. Neurology 1984;34:S186.
4. Graus F, Elkon KB, Cordon-Cardo C, Posner JB. Sensory neuronopathy and small cell lung cancer. Antineuronal antibody that also reacts with the tumor. Am J Med 1986;80:45-52.
5. Sillevis Smitt PAE, Leeuw B de, Vecht ChJ. Immunologie in de medische praktijk. XVI. Paraneoplastische syndromen van het zenuwstelsel: pathogenese en diagnostiek. Ned Tijdschr Geneeskd 1998;142:1652-8.
6. Lucchinetti CF, Kimmel DW, Lennon VA. Paraneoplastic and oncologic profiles of patients seropositive for type I antineuronal nuclear autoantibodies. Neurology 1998;50:652-7.
7. Condom E, Vidal A, Rota T, Graus F, Dalmau J, Ferrer I. Paraneoplastic intestinal pseudo-obstruction associated with high titres of Hu autoantibodies. Virchows Arch A Pathol Anat Histopathol 1993;423:507-11.
8. Bradley WG, Daroff RB, Fenichel GM, Marsden CD, editors. Neurology in clinical practice. Primary and secondary tumors of the central nervous system. Paraneoplastic syndromes. Oxford: Butterworth-Heinemann; 2000. p. 1299-307.
9. Dalmau J, Posner JB. Neurologic paraneoplastic antibodies (anti-Yo; anti-Hu; anti-Ri): the case for a nomenclature based on antibody and antigen specificity [letter]. Neurology 1994;44:2241-6.
10. Dalmau J, Graus F, Rosenblum MK, Posner JB. Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine (Baltimore) 1992;71:59-72.
11. Graus F, Keime-Guibert F, René R, Benyahia B, Ribalta T, Ascaso C, et al. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain 2001;124(Pt 6):1138-48.
12. Graus F, Dalmau J, René R, Torà M, Malats N, Verschuuren JJ, et al. Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival. J Clin Oncol 1997;15:2866-72.
13. Dalmau J, Furneaux HM, Gralla RJ, Kris MG, Posner JB. Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer - a quantitative western blot analysis. Ann Neurol 1990;27:544-52.
14. Verschuuren JJ, Perquin M, Velde G ten, Baets M de, Breda Vriesman P van, Twijnstra A. Anti-Hu antibody titre and brain metastases before and after treatment for small cell lung cancer. J Neurol Neurosurg Psychiatry 1999;67:353-7.
15. Briellmann RS, Sturzenegger M, Gerber HA, Schaffner TS, Hess CW. Autoantibody-associated sensory neuronopathy and intestinal pseudo-obstruction without detectable neoplasia. Eur Neurol 1996;36:369-73.
16. Chartrand-Lcfebvre C, Howarth N, Grenier P, Keime F, Orcel B, Beigelman C. Association of small cell lung cancer and the anti-Hu paraneoplastic syndrome: radiographic and CT findings. AJR Am J Roentgenol 1998;170:1513-7.
17. Antoine JC, Cinotti L, Tilikete C, Bouhour F, Camdessanche JP, Confavreux C, et al. [18F]fluorodeoxyglucose positron emission tomography in the diagnosis of cancer in patients with paraneoplastic neurological syndrome and anti-Hu antibodies. Ann Neurol 2000;48:105-8.
18. Comans EFI, Hoekstra OS, Hoekman K, Hoeven JJM van der, Golding RP, Teule GJJ. Meerwaarde van positronemissietomografie met als tracer fluor-18-deoxyglucose (FDG-PET) bij klinische probleemgevallen in de oncologie. Ned Tijdschr Geneeskd 2000;144:1520-8.
19. Janssen-Heijnen MLG, Dijck JAAM van, Siesling S, Schipper RM, Damhuis RAM. Longkanker in Nederland in de periode 1989-1997: de epidemie is nog niet voorbij. Ned Tijdschr Geneeskd 2001;145:419-23.
20. Keime-Guibert F, Graus F, Broët P, René R, Molinuevo JL, Ascaso C, et al. Clinical outcome of patients with anti-Hu-associated encephalomyelitis after treatment of the tumor. Neurology 1999;53:1719-23.
21. Darnell RB, DeAngelis LM. Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies. Lancet 1993;341:21-2.
22. Keime-Guibert F, Graus F, Fleury A, René R, Honnorat J, Broët P, et al. Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone. J Neurol Neurosurg Psychiatry 2000;68:479-82.